Estradiol + Progesterone + Placebo

Phase 3Completed

0 watching 0 views this week📈 Rising

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Menopause

Conditions

Menopause

Trial Timeline

Aug 5, 2013 → Oct 28, 2016

NCT ID

NCT01942668

About Estradiol + Progesterone + Placebo

Estradiol + Progesterone + Placebo is a phase 3 stage product being developed by TherapeuticsMD for Menopause. The current trial status is completed. This product is registered under clinical trial identifier NCT01942668. Target conditions include Menopause.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01942668	Phase 3	Completed	Aug 5, 2013	Oct 28, 2016	Menopause

Competing Products

20 competing products in Menopause

See all competitors

Product	Company	Stage	Hype Score
atomoxetine + placebo	Eli Lilly	Pre-clinical	23
Fezolinetant + Placebo	Astellas Pharma	Phase 2	52
Cetrorelix	Shionogi	Pre-clinical	23
Teriparatide (PTH 1-34)	Eli Lilly	Phase 2/3	65
Eszopiclone + Placebo	Sumitomo Pharma	Pre-clinical	23
Comparator: placebo + Comparator: Estrace	Merck	Phase 1	33
esmirtazapine + Placebo	Merck	Phase 3	77
Marketed low dose hormone replacement therapy	Novo Nordisk	Pre-clinical	22
0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA)	Novo Nordisk	Pre-clinical	22
1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA)	Novo Nordisk	Approved	84
estradiol, 10 mcg + estradiol, 25 mcg + placebo	Novo Nordisk	Phase 3	76
0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) + 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA) + 1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA)	Novo Nordisk	Phase 1	32
estradiol, 25 mcg	Novo Nordisk	Pre-clinical	22
estradiol, 10 mcg	Novo Nordisk	Phase 3	76
estradiol, 10 mcg + estradiol, 25 mcg	Novo Nordisk	Phase 1	32
estradiol, 10 mcg	Novo Nordisk	Phase 3	76
2 mg estradiol / 1 mg norethisterone acetate (NETA)	Novo Nordisk	Phase 1	32
estradiol, 25 mcg	Novo Nordisk	Phase 3	76
estradiol, 25 mcg	Novo Nordisk	Phase 3	76
0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) + 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA) + placebo	Novo Nordisk	Phase 3	76

Other Products from TherapeuticsMD

Progesterone + PlaceboPhase 3

Estradiol + PlaceboPhase 3

oral estradiol 1.0 mg + oral progesterone 100 mgPhase 3

Estradiol + placeboPhase 2

Segesterone Acetate and Ethinyl EstradiolPhase 1